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Protein modification by ubiquitin (UB) controls
diverse cellular processes. UB is conjugated to
cellular proteins by sequential transfer through an
E1-E2-E3 enzymatic cascade. The cross-activities
of 2 E1s, 50 E2s and thousands of E3s encoded by
the human genome make it difficult to identify the
substrate proteins of a specific E3 enzyme in the
cell. One way to solve this problem is to engineer
an orthogonal UB transfer (OUT) cascade in which
the engineered UB (xUB) is relayed by engineered
E1, E2 and E3 enzymes (xE1, xE2, xE3) to modify
the substrate proteins of a specific E3. Here, we
use phage display and mutagenesis to construct
xUB-xE1 and xE1-xE2 pairs that are orthogonal to
the native E1 and E2 enzymes. Our work on engi-
neering the UB transfer cascades will enable us to
use OUT to map the signal transduction networks
mediated by protein ubiquitination.
INTRODUCTION
Ubiquitin (UB) is transferred through an E1-E2-E3 enzymatic
cascade to the substrate proteins to regulate their intracellular
stability and biological functions (Hershko and Ciechanover,
1998). E1, the UB activating enzyme, activates UB in a two-
step process whereby UB-AMP conjugate is formed via the
condensation reaction between the UB C-terminal carboxylate
and a molecule of ATP. Subsequently, the catalytic Cys residue
of E1 captures the activated UB with the formation of a thioester
bond between the thiol group of Cys and the C-terminal Gly
residue of UB. UB in the UBE1 conjugate (an approximation
symbol designates the thioester linkage) is then transferred to
a catalytic Cys residue of an E2, also known as UB-conjugating
enzyme, to form an UBE2 conjugate. Finally, E3 UB ligases of
HECT, RING, or U-box types bridge the interaction between
UBE2 and substrate proteins in the cell to facilitate UB transfer
to the substrate proteins (Figure 1A; Figure S1A available online)Chemistry & Biology 19, 1265–1(Pickart, 2001). So far, 2 E1s, 50 E2s, and more than 1,000 E3s
have been identified in the human genome (Deshaies and
Joazeiro, 2009; Wenzel et al., 2011). It has been shown that
the two human E1 enzymes, Ube1 and Uba6, have overlapping
yet distinct activities in transferring UB to various E2s (Jin
et al., 2007). Each E2 interacts with multiple E3s, and each E3
can recognize multiple substrate proteins for UB modification
(Deshaies and Joazeiro, 2009; Wenzel et al., 2011). Furthermore,
multiple E2s can pair with the same E3, and different E2-E3
pairs may attach UB chains of different lengths and topologies
to the substrate proteins. Together, the E1, E2, and E3 enzymes
assemble a complex network of UB transfer pathways for the
modification of cellular proteins (Figure S1A).
Biochemical mechanisms of UB activation by E1 and transfer
through the E1-E2-E3 cascade have been relatively well estab-
lished (Pickart, 2001). However, interactions between E2 and
E3 enzymes, and between E3 and their substrate proteins,
have been more difficult to study given the substantial cross-
reactivities among them. Therefore, the biological functions of
individual E2 and E3 enzymes in regulating protein ubiquitination
and degradation are yet to be clearly defined.
We propose to untangle the complexity of protein ubiquitina-
tion networks in the cell by creating an orthogonal UB transfer
pathway that is composed of engineered E1, E2, and E3
enzymes (xE1, xE2, and xE3) (Figure 1A; Figure S1B). The xE1-
xE2-xE3 cascade would share no cross-reactivity with the
native enzymes and enable the transfer of an affinity-tagged
UB mutant (xUB) to engineered xE2 and xE3 enzymes and
eventually to the substrate proteins of xE3. By identifying
proteins conjugated to xUB, themodification targets of a specific
xE3 in the cell can be elucidated. We refer to this method as
orthogonal UB transfer (OUT).
Engineering the OUT cascade requires three steps (Figure 1A).
The first step requires the generation of an xUB-xE1 pair that can
only activate xUB to form the xUBxE1 conjugate and allow
xUB entry into the OUT cascade without activating wild-type
(wt) UB (wtUB). In the second step, an xE1-xE2 pair that exclu-
sively transfers xUB from xE1 to an engineered xE2 without
transferring xUB to any of the wtE2s in the cell is needed. The
third and final step uses an xE2-xE3 pair to transfer xUB to the
substrate proteins of xE3, using xE2 that only binds to the engi-
neered xE3 but not to any wtE3 to ensure the exclusive transfer277, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1265
Figure 1. The Orthogonal UB Transfer
Cascade
(A) Engineering xUB-xE1, xE1-xE2, and xE2-xE3
pairs for OUT.
(B) Bump-and-hole strategy to create specific
interactions between xUB and xE1.
See also Figures S1, S2, and S4.
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As a final note, since xUB is fused to an affinity tag such as
hemagglutinin (HA) or FLAG, the ubiquitination targets of the
xE3 enzymes can be enriched by affinity purification and then
identified by mass spectrometry.
Here we report that we have successfully engineered specific
xUB-xE1 and xE1-xE2 pairs as the first two steps to implement
the OUT cascade. We first generated E1 mutants with mutations
in the adenylation domain, xE1(A), that do not bind wtUB. We
then used a combination of phage selection and site-directed
mutagenesis to introduce complementary mutations into UB
to restore the binding between xUB and xE1(A). This enables
the activation of xUB by xE1(A) for the transfer of xUB through
the OUT cascade and results in an xUB-xE1(A) pair fully orthog-
onal to the native UB-E1 pair.
In the next step, we engineered specific xE1-xE2 pairs using
a similar strategy. We first prepared xE1(UFD) by introducing
mutations into the ubiquitin fold domain (UFD) domain of
E1 (Lee and Schindelin, 2008) to block its interaction with the
native E2s, followed by phage selection to identify compatible
mutations in E2 that restore interaction with xE1(UFD). We also
combined the mutations in xE1(A) and xE1(UFD) to create an
xE1 that can transfer xUB to a specific xE2 but not to native
E2s. Additionally, xE2 only takes xUB from the xE1 but does
not accept wtUB from a wtE1, ensuring exclusive transfer of
xUB in the xE1-xE2 relay (Figure 1A). We also identified key
sites in the H1 helix motif of E2 that are important for E1 recog-
nition and showed that we can assemble xE1-xE2 pairs with
different E2s by replacing the H1 helix in the native E2 with
an H1 helix mutant. The creation of orthogonal UB transfer1266 Chemistry & Biology 19, 1265–1277, October 26, 2012 ª2012 Elsevier Ltd All rights respathways through engineered xE1 and
xE2 enzymes paves the way for us to
implement an OUT cascade in the cell to
profile the substrate specificities of E3s.
RESULTS
Structure-Based Design
of the UB-E1 Interface
Following the ‘‘bump-and-hole’’ strategy
(Alaimo et al., 2001; Hwang and Miller,
1987) to engineer the UB-E1 interface,
we first introduced mutations into the ad-
enylation domain of E1 to create amutant
that does not bind and activate wtUB
(Figure 1B). Our design of E1 mutations
was based on the crystal structure
of Uba1, the yeast E1 enzyme, with an
UB molecule bound noncovalently to
the adenylation domain of Uba1 (Fig-ure S2A) (Lee and Schindelin, 2008). The crystal structure
suggests that the C-terminal residues of UB with the sequence
71LRLRGG76 make extensive contacts with the Uba1 active
site. Among them, Arg72 plays a key role in binding to E1 since
its side chain docks in a negatively charged pocket in the
Uba1 adenylation domain (Figure S2B). The binding pocket is
composed of the side chains of Gln576, Asp591, and the
backbone carbonyl groups of Tyr586 and Ser589 of Uba1.
Besides Arg72, Arg74 is another positively charged residue at
the UB C terminus, and makes electrostatic interactions with
Glu594 of Uba1.
To create unfavorable interactions between mutant E1 and
wtUB, we generated three Uba1 mutants, A1, A2, and A3
(Table 1). A1 and A2 are triple mutants, with Gln576 and
Glu594 both mutated to Arg and Asp591 mutated to either
Arg or Asn. The A3 mutant leaves Gln576 intact, but it has
Asp591 mutated to Asn and Glu594 mutated to Arg. We found
by ATP-PPi exchange assay (Haas and Rose, 1982) that neither
A1 nor A2 is able to activate wtUB (Figure S3A). However, A3
can still activate wtUB at a rate slightly lower than wtUba1.
We attribute the difference in activity to the strong repulsive
interaction between Arg72 of wtUB and the Arg residue replac-
ing Gln576 in A1 and A2, which is absent from A3 (Figure S2B).
We also tested the formation of UBE1 thioester conjugates
by western blot. We found that wtUB with an N-terminal
HA tag (HA-UB) cannot form UBE1 conjugates with A1 or
A2, while it can with A3 (Figure S3B). Based on the orthogo-
nality of A1 with wtUB, we decided to use the A1 mutant
to select for compatible mutations in UB to engineer the
xUB-xE1 pair.erved
Table 1. Mutants of Uba1 and UB Used in This Study
UB Mutants Mutated Residues
UB8 R72E
UB9 R42D, R72E
UB10 (xUB) R42E, R72E
E1 (Uba1) mutants
xE1 (A) with mutations in the adenylation (A) domain
A1 Q576R, D591R, E594R
A2 Q576R, D591N, E594R
A3 D591N, E594R
A4 Q576R, S589R
A5 Q576R, S589R, D591R
A6 Q576R, D591R
xE1 (UFD) with mutations in the ubiquitin fold domain (UFD)
A7 E1004K, D1014K, E1016K
xE1 with combined mutations in the A and UFD domains
A8 Q576R, S589R, E1004K, D1014K, E1016K
A9 Q576R, S589R, D591R, E1004K, D1014K, E1016K
A10 Q576R, D591R, E1004K, D1014K, E1016K
E2 mutants with swapped H1 helix with Ubc1 mutants
C1-UbcH5a 1MSRAEDIMEQIL12 replacing H1 helix of UbcH5a
C9-UbcH5a 1MSRADEIMEQIL12 replacing H1 helix of UbcH5a
C2-UbcH7 1MSRADDIMDQIH12 replacing H1 helix of UbcH7
C9-UbcH7 1MSRADEIMEQIL12 replacing H1 helix of UbcH7
See also Figure S2.
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To create UB mutants with restored binding to A1, we con-
structed a library of UB variants with randomized C-terminal
sequences and used phage display to select for UB mutants
that are reactive with A1 (Figure S4A). To construct the UB library
for phage selection, we randomized the C-terminal 71LRLRG75
sequence of UB, since these residues may interact with the
mutated Gln576, Asp591, and Glu594 side chains in A1 (Fig-
ure S2B). We amplified the UB gene with primers Jun13 and
Bo74 by the PCR and cloned the amplified PCR fragments into
the pJF3H phagemid (Figure S4B) (Barbas et al., 2000; Crameri
and Suter, 1993). The Bo74 primer had NNK codons (N, any of
A, T, G, or C; and K, either G or T) encoding residues 71–75 of
UB (Table S1). The final diversity of the library was approximately
1 3 108, large enough to cover all the UB mutants with five
randomized residues at their C termini. We confirmed the display
of UB on phage surface with an anti-HA antibody in ELISA and
western blot assays (Kay et al., 1996) (Figures S4C and S4D).
To carry out phage selection, we first expressed the Uba1-A1
mutant as a fusion to the peptidyl carrier protein (PCP) (Fig-
ure S4A) (Yin et al., 2006). We then used the Sfp phosphopan-
tetheinyl transferase to catalyze the transfer of a biotin
phosphopantetheinyl (Ppant) group from biotin CoA to a Ser
residue in PCP. Biotin-conjugated PCP-A1 fusion was then
immobilized on a plate coated with streptavidin. We added
the phage displayed UB library and ATP to the plate to initiate
UB activation by A1. Once UB variants displayed on the phage
surface were activated and formed a thioester linkage with A1,
the corresponding phage particles were covalently bound toChemistry & Biology 19, 1265–1the streptavidin surface. After the plate was washed, the bound
phage were eluted with dithiothreitol (DTT) that cleaved the
thioester bond in the UBA1 complex. We set up model
selections to show that one round of phage selection enriched
UB phage from a mixture of phage displaying the V protein of
the simian virus 5 (SV5V) (Ulane and Horvath, 2002) by more
than 500-fold (Figures S4E–S4G). These results demonstrated
that phage display can be used to select for A1-reactive UB
mutants with high efficiency.
Phage Selection of the UB Library
We then carried out iterative rounds of phage selection of the
UB library. In each round, the number of phage particles used
in the selection, the amount of PCP-A1 fusion coated on the
streptavidin plate, and the reaction time were decreased to
make the selection more stringent. In parallel with the selection,
we also set up controls in which either ATP or PCP-A1 was
excluded from the selection reaction. We observed a steady
increase of the phage enrichment from the selection reaction
over the controls (Figure 2A). After the sixth round of selection,
we saw an enrichment greater than 500-fold of the UB-displayed
phage over the controls in which no PCP-A1 was bound to
the plate for UB conjugation. This is a strong indication that
phage were selected to bind to the streptavidin plate based
on the catalytic formation of UBA1 thioester conjugates. We
sequenced 40 phage clones from the sixth round of selection.
The alignment of theC-terminal sequences of the selected phage
clones is shown in Figure 2B, with the 71FEFFGG76 sequence
found in UB1 clone being the most dominant in the selected
pool. UB1 appeared 14 times out of 40 sequenced clones and
others, such as UB2 and UB5, also appeared multiple times.
Alignment of the selected clones revealed a clear pattern of
the C-terminal sequences that can be activated by A1. Most
clones had a negatively charged residue at position 72, replacing
the wt Arg, likely because of the need to compensate for the
Gln576Arg mutation in A1. To our surprise, positions 71, 73,
and 74 of the UB mutants preferred bulky aromatic side chains
such as Phe, Tyr, or Trp, quite different from the Leu or Arg resi-
dues found in wtUB (Figure 3B). To examine this further, we used
a model of UB1 binding to A1 based on the crystal structure of
the UB-Uba1 complex (Lee and Schindelin, 2008) and showed
that the mutated residues in UB1 and A1 can be accommodated
without significant adjustments of the peptide backbones of
either UB or Uba1 (Figure S2C). In the resulting model, Glu72
in UB1 was engaged in electrostatic interactions with the side
chains of Arg576 and Arg594 that were introduced into A1 by
mutagenesis. The three Phe residues flanking Glu72 in UB1,
although larger in size than the Leu or Arg residues in wtUB,
did not exhibit any steric clashes with the residues of A1 at the
UB binding site. Instead, the modeled complex suggested that
the Arg74Phe mutation of UB1 may be a good match with the
Glu594Argmutation in A1 (Figure S2C). As shown in themodeled
structure, the Arg74Phe mutation in UB1 not only abolished the
electrostatic repulsion between Arg74 of wtUB and Arg594 of
A1, but also positioned a Phe residue at the UB C terminus
that could potentially stabilize the positively charged Arg594
residue of A1 by cation-p interactions.
We expressed UB mutants corresponding to the selected
phage clones UB1, UB2 and UB5.We found that the UBmutants277, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1267
Figure 2. Phage Selection of Catalytically Active UB Mutants with A1
(A) Phage titer of each round of selection. Phage selection of the UB library was performed in parallel to the controls in which either A1 or ATP was excluded
from the reaction. Numbers of the eluted phage from the streptavidin plate for the selection and control reactions are plotted on a logarithmic scale. cfu, colony
forming unit.
(B) Alignment of the C-terminal sequences of the selected UBmutants after the sixth round of selection. Stars denote the C-terminal sequence of UB (71LRLRG75)
that was randomized in the phage library. Gly76 is the last residue at the UB C terminus.
(C and D) Western blot analysis of the reactivities of UB mutants with A1 and wtUba1. (C) A1 cannot activate wtUB but can activate phage-selected UB mutants
UB1, UB2, and UB5 to form thioester conjugates. (D) wtUba1 is reactive with wtUB, UB1, UB2, and UB5.
(E) UB mutants UB9 and UB10 are not reactive with either wtUba1 or Uba1-A1.
See also Figures S2–S5.
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exchange assay (Figure S5A). The same mutants can also be
activated by the wtUba1 based on ATP-PPi exchange, although
at a rate of about half of the wtUB (Figure S5B). We also found by
western blot that the UB clones UB1, UB2, and UB5 can form
thioester conjugates with both A1 and wtUba1 (Figures 2C and
2D). In contrast, wtUB cannot form covalent intermediates
with A1 (Figure 2C). These results suggest that phage selection
did enrich UB mutants that are reactive with A1. However, these
UB mutants still have residual activity with wtUba1. This notion
is confirmed by characterizing the kinetics of UB1 activation by
A1 and wtUba1 based on ATP-PPi exchange (Haas and Rose,
1982) (Table 2). We found that the catalytic efficiency (kcat/K1/2)
of the UB1-A1 pair (19 mM1min1) is similar to that of the
wtUB-wtUba1 pair (35 mM1min1). However, the kcat/K1/2 of
UB1 with wtUba1 (1.9 mM1min1) is about one tenth of the
UB1-A1 pair largely because of the increase in K1/2 of the UB1
mutant with wtUba1. Still based on the ATP-PPi exchange
data, the UB1mutant can be efficiently activated by the wtUba1.
To test the specific role of Arg72Glu mutation, we generated an
Arg72Glu UB mutant (UB8) and tested its activity. We found that
UB8 is activated by both wtUba1 and A1 at high efficiency to
form UBE1 conjugates (Table 1; Figures S5C and S5D). Thus,
additional mutations are needed to completely eliminate UB81268 Chemistry & Biology 19, 1265–1277, October 26, 2012 ª2012 Einteraction with wtUba1 in order to generate an xUB-xE1 pair
that is orthogonal to the native UB transfer cascades.
Site-Directed Mutagenesis to Create an xUB-xE1 Pair
that Is Orthogonal to the Native UB-E1 Pair
We identified another critical binding interface between UB
and Uba1 that involves hydrogen bonding and electrostatic
interactions between Arg42 of UB and Ser589 and Asp591 of
Uba1 (Figure S2B). We thus introduced additional mutations
to UB8 by changing Arg42 to Asp or Glu (mutants UB9 and
UB10; Table 1). The ATP-PPi exchange assay showed that
they can neither be activated by wtUba1 to any significant
level (Figure S5E), nor can they form thioester conjugates with
wtUba1 (Figure 2E). Thus, charge-reversed double mutations
of UB at the sites of Arg42 and Arg72 disturb the interactions
between UB and wtUba1 so that wtUba1 can no longer activate
the UB mutants. We also found the A1 cannot activate UB9 and
UB10 to form UBA1 conjugates (Figure 2E). We thus needed
to introduce complementary mutations into Uba1 to restore its
interaction with the UB mutants. Based on the crystal structure
of UBUba1 complex, we decided to test two double mutants,
A4 (Gln576Arg/Ser589Arg), and A6 (Gln576Arg/Asp591Arg),
and a triple mutant A5 (Gln576Arg/Ser589Arg/Asp591Arg)
(Table 1).lsevier Ltd All rights reserved
Figure 3. Reactivity of the xUB-xE1(A) Pair Assembled by UB Mutant UB10 and Uba1 Mutant A5
(A) UB mutants UB9 and UB10 can be activated by Uba1 mutants A4, A5, and A6 to form UBE1 conjugates.
(B) Polyubiquitination of CHIP using UB10 as the xUB, Uba1-A5 as xE1, and UbcH5a as E2. wtUB transfer to CHIP bywtUba1 andUbcH5a was used as a control.
(C) xUB (UB10) transfer to the RING domain of Mdm2 catalyzed by xE1 (Uba1-A5) and UbcH5b.
(D) Formation of UBHECT thioester conjugate between xUB (UB10) and the HECT domain of Rsp5. DTT at 150 mM was added to the xUB transfer reaction in
the last lane to cleave the thioester bond of the UBHECT conjugate.
(E) Formation of UBHECT thioester conjugate between xUB (UB10) and the HECT domain of E6AP. DTT at 150mMwas also added to the xUB transfer reaction
in the last lane.
See also Figures S2 and S5.
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mutants showed that A4, A5, and A6 can catalyze the formation
of UBE1 conjugates with UB9 and UB10 (Figure 3A). Based on
the western blot, A4 and A5 catalyze the formation of UBE1
conjugates more efficiently than A6. Since both A4 and A5
contain Ser589Arg mutation, but A6 does not, it seems that an
Arg at position 589 is the key to establish interactions with an
Asp or Glu side chain in the UB mutants. None of A4, A5, or A6
can activate wtUB for the formation of UBE1 conjugates
(Figure 3A). We also used UB mutant UB10 and Uba1 mutant
A5 as a specific pair to characterize the kinetics of UB activa-
tion by ATP-PPi exchange. As shown in Table 2, UB10 is
activated by A5 with a kcat/K1/2 of 16 mM
1min1, matching theChemistry & Biology 19, 1265–1corresponding values of the wtUB-wtE1 pair with a kcat/K1/2
of 35 mM1min1. In contrast, the crossover pairs UB10-wtE1
and wtUB-A5 have very low activity of ATP-PPi exchange. These
crossover pairs have a kcat/K1/2 more than 1,000-fold lower than
that of the wt pair or the engineered pair (Table 2). These results
clearly demonstrate the orthogonality between the UB10-A5
pair and the wtUB-wtUba1 pair. We also measured the activa-
tion kinetics of UB8 by A5 and wtUba1. Based on ATP-PPi
exchange, we found that UB8 can be activated by A5 at a kcat/
K1/2 of 22 mM
1min1, approaching that of the wtUB-wtUba1
pair (35 mM1min1) (Table 2). The kcat/K1/2 of UB8 with the
wtUba1 is 0.075 mM1min1, much smaller than that of UB8
activation by A5. The drastically different reactivity of UB8 with277, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1269
Table 2. Kinetics of UB Activation by wtUba1 and Uba1 Mutants Measured by ATP-PPi Exchange Assay
UB – E1 pairs K1/2 (mM) kcat (min
1) kcat/K1/2 (mM
1 min1) UB – E1 pairs K1/2 (mM) kcat (min
1) kcat/K1/2 (mM
1 min1)
UB1 – wtUba1 8.2 ± 0.2 15 ± 3 1.9 UB1–Uab1-A1 2.0 ± 0.4 38 ± 7 19
UB8 – wtUba1 0.075 UB8–Uba1-A5 1.4 ± 0.3 31 ± 2 22
Cross-reactivity of UB10–Uba1-A5 with wtUB-wtUba1 pair
UB10 – wtUba1 0.012 UB10–Uba1-A5 4.4 ± 0.5 70 ± 9 16
wtUB – wtUba1 1.4 ± 0.1 50 ± 5 35 wtUB–Uba1-A5 0.011
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disrupts the binding of UB8 with wtUba1, but this mutation is
compensated by the Gln576Arg mutation in A5 to afford high
activity of UB8 with A5. It is interesting that the kcat/K1/2 of the
UB8-wtUba1 pair (0.075 mM1min1) is 6-fold higher than the
UB10-wtUba1 pair (0.012 mM1min1) (Table 2). This suggests
that the additional Arg42Glu mutation in UB10 further decreased
the activity of the UB mutant with wtUba1.
We then used UB10 and A5 to assemble an xUB-xE1 pair and
assayed if they can transfer xUB to E2 and E3 enzymes such as
UbcH5a and CHIP. CHIP is an U-box dependent E3 enzyme
(Jiang et al., 2001) that can be autoubiquitinated by uptaking
UB from E2 enzyme UbcH5a. We tested if the UB10-A5 pair
can support CHIP autoubiquitination by transferring UB10 to
UbcH5a and then to CHIP. As shown in Figure 3B, when CHIP
was incubated with HA-UB10, A5 and UbcH5a, intense ubiquiti-
nation of CHIP was detected on the western blot with an anti-HA
antibody. The smear of HA-UB10-conjugated species on the
western blot suggests the modification of CHIP with multiple
copies of UB10. The pattern of CHIP polyubiquitination with
UB10 and A5 is similar to CHIP polyubiquitination with wtUB
and wtE1 (Figure 3B). This demonstrated that the UB10-A5
pair can function as well as the wtUB-E1 pair in supporting UB
transfer to E2 and to E3 enzymes. We also obtained similar
results when UB10 and A5 were used with UbcH5b as E2 and
the RING domain of Mdm2 as E3 (Figure 3C). To test the transfer
of UB10 to the HECT E3s, the HECT domains of Rsp5 and E6AP
(Huang et al., 1999; Huibregtse et al., 1997) were reacted with
UB10, A5, and E2 enzyme Ubc1 or UbcH7 for the formation of
UB10HECT thioester conjugates (Figures 3D and 3E). We
found that UB10 can be efficiently transferred to the HECT
domains through the relay of A5 and the E2s just as the transfer
of wtUBmediated by wtUba1 and the E2s. We further confirmed
the formation of a thioester linkage in theUB10HECT conjugate
by treating the reaction mixture with 150 mM DTT prior to
SDS-PAGE and western blot analysis. As expected, the UB
transfer reactions with DTT treatment showed no UBHECT
conjugates on the western blot. This suggested that UB10 was
transferred by A5 and the E2 enzymes to the HECT domains
of Rsp5 and E6AP to form thioester conjugates. We have
thus demonstrated that UB10 and A5 can be used as an xUB-
xE1(A) pair for the construction of the OUT cascade.
Structure-Based Design of the E1-E2 Interface for the
Creation of an xE1-xE2 Pair
Following our success to engineer the UB binding site of Uba1 to
generate orthogonal xUB-xE1 pairs, we continued to engineer
the E2 binding site of Uba1 to create orthogonal xE1-xE2 pairs.
Again, we relied on structural information to guide the design of1270 Chemistry & Biology 19, 1265–1277, October 26, 2012 ª2012 ExE1-xE2 interface (Figures S2A and S2D). There is no crystal
structure of an UB E1 in complex with an E2 enzyme, however,
the crystal structure of the Nedd8-activating E1 (NAE) has
been solved in a complex with an E2 enzyme Ubc12 and the
Nedd8 protein (Huang et al., 2007) and, given the similarities
between Nedd8 and NAE with UB and Uba1, respectively, the
NAE-Ubc12-Nedd8 complex structure can be used to guide
our design. In NAE-Ubc12-Nedd8 complex, Ubc12 binds to
Uba3 through direct interactions between the N-terminal H1
helix of Ubc12 and the C-terminal UFD domain of Uba3 (Huang
et al., 2007). Given the structural homology between NAE
and Uba1 (Schulman and Harper, 2009) and the modeling
study on Uba1 binding to a yeast E2 Ubc1 (Lee and Schindelin,
2008), we expected H1 helix of E2 to be a key contributor to
E1 binding.
Previous work has also established that Uba1 and Ubc1 bind
to each other through electrostatic interactions between three
acidic residues (Glu1004, Asp1014, and Glu1016) of the UFD
domain of Uba1 and a number of basic residues (Lys5, Arg6,
Lys9, and Glu10) in the H1 helix of Ubc1 (Figure S2D). Mutations
at these residues that reversed the charges of the side chains
(Lys to Glu, or Glu and Asp to Lys) significantly reduced UB
transfer from Uba1 to Ubc1 (Lee and Schindelin, 2008). The
double mutations Lys5Glu and Lys9Glu in the H1 helix of Ubc1
were shown to block the formation of UBE2 conjugates
(Lee and Schindelin, 2008). These studies identified a ‘‘hotspot’’
on Uba1 that is composed of Glu1004, Asp1014, and Glu1016
for E2 binding. To acquire an Uba1 mutant that rejects native
E2s, we constructed an A7 mutant of Uba1 with Glu1004,
Asp1014, and Glu1016 of Uba1 replaced by Lys following the
previous report (Lee and Schindelin, 2008) (Table 1). We found
that A7 can no longer loadUBon to native E2s such asUbc1, Ub-
cH5a, and UbcH7 (Figure 4A). Since the mutations of A7 were
in the UFD domain of Uba1, quite distant from the UB binding
site of the E1 enzyme, we confirmed by ATP-PPi exchange and
western blot that A7 functions as wtUba1 in UB activation and
formation of UBE1 conjugate. We thus decided to use A7 as
the xE1(UFD) for the engineering of the xE1-xE2 pair.
Phage Selection of Catalytically Active E1-E2 Pairs
Next, we engineered Ubc1 with complementary mutations
so that it could specifically interact with A7. For this purpose,
we constructed an Ubc1 library with randomized residues at
Lys5, Arg6, Lys9, Glu10, and Gln12, which are all on the same
side of H1 helix, facing the UFD domain of A7. We then used
phage display to select Ubc1 mutants with restored binding
and reactivity with A7.
We developed a phage display method to engineer an E2
enzyme based on the formation of the UBE2 thioesterlsevier Ltd All rights reserved
Figure 4. Engineering UB Transfer from
E1 to E2
(A) UB transfer from wtUba1 and A7 to wild-type
Ubc1, UbcH5a, and UbcH7.
(B) The phage selection scheme for the engi-
neering of orthogonal xE1-xE2 pairs. UB is labeled
with biotin, and it can be transferred to E2 variants
displayed on phage surface by the E1 mutant
xE1(UFD). Phage-displaying E2 variants conju-
gated to biotin-UB are selected by binding to the
streptavidin surface.
(C) Alignment of phage-selected Ubc1 mutants
with wt Ubc1, UbcH5a, and UbcH7. Randomized
residues in the H1 helix of the Ubc1 library are
shown in red.
(D) UB transfer from A7 to the Ubc1 mutants C1,
C2, C9, C14, and C16 from phage selection.
(E) UB transfer from wtUba1 to the Ubc1 mutants
from phage selection.
See also Figures S2, S6, and S7.
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Orthogonal Ubiquitin Transferconjugate catalyzed by E1 (Figure 4B). In this method, we dis-
played the E2 enzyme on phage with the pCom3H phagemid
(Barbas et al., 2000). We also prepared biotin conjugated
UB by expressing UB with a 11-residue ybbR tag fused to its
N terminus (Yin et al., 2006). We then used the Sfp enzyme to
covalently attach biotin to a Ser residue in the ybbR tag through
a phosphopantetheinyl linker. To use phage display to select for
E2 variants that could uptake UB from A7, we combined ATP,
biotin-conjugated UB (biotin-UB), and A7 with the phage-dis-
played E2 library. In the reactionmixture, biotin-UBwas first acti-
vated by A7 to form a biotin-UBA7 thioester (Figure 4B). The
activated biotin-UB was then transferred to phage-displayed
E2 variants that could bind to A7. Through this process, phage
particles displaying E2 variants that were reactive with A7 were
labeled with biotin due to the formation of biotin-UBE2 con-
jugates. These phage particles were selected by binding to a
streptavidin surface. After washing to remove phage not labeled
with biotin, the bound phage were eluted from the streptavidin
surface with 10 mM DTT that cleaved the thioester bond
between biotin-UB and E2. Eluted phage were amplified for
the subsequent round of reaction with biotin-UB and A7. By
model selection, we confirmed that one round of selection was
able to enrich Ubc1 phage from a mixture with phage displaying
the EntE protein (Ehmann et al., 2000) by more than 100-fold
(Figure S6C). We then carried out iterative rounds of selection
of the E2 library to identify variants that could pair with A7.
Phage Selection of an Ubc1 Library to Identify xE2
Through rounds of selection, we observed a steady increase
in phage enrichment compared to the controls in which eitherChemistry & Biology 19, 1265–1277, October 26, 2012 ªA7 or biotin-UB was excluded from the
reaction (Figure S6D). At the end of the
eighth round of selection, the phage
enrichment of the selection reaction
over the controls was more than 1,000
fold. This was a strong indication that
the library had converged to a pool of
E2 clones that are catalytically activewith A7. We sequenced phage clones after the eighth round of
selection. The alignment of the H1 helix region of the selected
Ubc1 clones is shown in Figure 4C. The most evident feature
of the selected clones was that most clones have negatively
charged Asp or Glu residues replacing positively charged
Lys5, Arg6, and Lys9 in wtUbc1. Furthermore, almost all
selected Ubc1 clones have a neutral side chain (Gln residue)
instead of Glu9 in wtUbc1. The residues replacing Gln12 were
less converged but still showed a bias for either hydrophobic
residues (Leu or Met) or positively charged residues such as
Lys and Arg.
Phage-Selected Ubc1 Mutants Can Function
as xE2 to Pair with A7
To verify the reactivity of phage-selected Ubc1 mutants with
A7, we expressed the Uba1 mutants C1, C2, C9, C14, and
C16 that appeared multiple times among the clones being
sequenced and assayed if they could form E2UB conjugates
catalyzed by A7. In the assay, we reacted HA-UB and A7 with
Ubc1 mutants in the presence of ATP. The reaction mixtures
were analyzed by SDS-PAGE under nonreducing conditions
to preserve the thioester linkage between UB and the E1 and
E2 enzymes. We then probed the western blot of the PAGE
gel with a mouse anti-HA antibody and a goat antimouse
antibody conjugated to horseradish peroxidase. As shown in
Figure 4D, HA-UB could be transferred by A7 to all the Ubc1
mutants selected by phage display as demonstrated by the
formation of UBUbc1 conjugates. In contrast, A7 could not
transfer biotin-UB to wtUbc1 at a noticeable level. We also
tested the reactivity of wtUba1 with the Ubc1 mutants and2012 Elsevier Ltd All rights reserved 1271
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Ubc1 mutants (Figure 4E). These results demonstrated that
UB can be exclusively transferred by A7 to the Ubc1 mutants.
Thus, the Ubc1 mutants identified in phage selection can
be used as xE2s to pair with A7 for the assembly of xE1-xE2
pairs.
The A7-xE2 Pair Can Transfer wtUB to E3 Enzymes
Next, we tested if Ubc1 mutants from phage selection could
transfer UB to a target E3, the HECT domain of E6AP, in the
presence of A7. From the crystal structure of the E2 enzyme
UbcH7 in complex with the HECT domain of E6AP (Huang
et al., 1999), and published mutational analysis (Eletr and
Kuhlman, 2007; Huang et al., 1999), it can be seen that the
N-terminal H1 helix of UbcH7, and especially residues Arg5,
Arg6, and Lys9 that correspond to Lys5, Arg6, and Lys9 in the
wtUbc1, contribute to UbcH7-HECT interaction (Figure S7A).
Given that, in the Ubc1 mutants from phage selection these
residues are most often replaced by Asp and Glu, we were inter-
ested in assaying if the mutant Ubc1 selected for interacting
with A7 could still support UB transfer to the HECT domain of
E6AP. Additionally, UbcH7 and Ubc1 share some additional
features, like Phe63, which are thought to be important for
HECT domain binding and, thus, wtUbc1 should be able to
interact with E6AP and support UB transfer (Huang et al.,
1999). Indeed, we found that the wtUba1-wtUbc1 pair could
transfer UB to the HECT domain of E6AP and the efficiency of
UB transfer similar to that of the wtUba1-wtUbcH7 pair (Fig-
ure S7B). We then tested the transfer of wtUB from A7 to the
E6AP HECT domain through Ubc1 mutants from phage selec-
tion. We observed significant transfer of wtUB to the E6AP
HECT domain through A7 and phage-selected Ubc1 mutants
C2, C9, and C14 as shown by the formation of wtUBHECT
conjugates (Figure S7C). This suggested that the Ubc1 mutants
with charge-reversed mutations in the H1 helix could still
interact with the HECT domain of an E3 enzyme to support
UB transfer in the E1-E2-E3 cascade. It was interesting that,
when we used the mismatched wtE1-mutant Ubc1 pair to trans-
fer UB to the E6AP HECT, we could not see any formation of the
UBHECT conjugate (Figure S7D). These results demonstrated
that the Ubc1 mutants from the phage selection were orthog-
onal to the native E1, but they could transfer UB to the down-
stream E3 enzymes by taking up UB from A7.
The wtUba1-wtUbc1 pair had previously been found to trans-
fer UB to the HECT domain of Rsp5 (Huibregtse et al., 1997).
We used the C9 mutant of Ubc1 as xE2 to test the transfer
of wtUB through the A7-xE2 pair to the HECT domain of
Rsp5. As shown in Figure S7E, the A7-xE2 pair could transfer
UB to the HECT domain of Rsp5 as demonstrated by the
formation of UBHECT conjugate. When either A7 or xE2
was excluded, UB attachment to the HECT domain was not
seen. Western blot analysis also showed that the A7-xE2 pair
transfers wtUB to the Rsp5 HECT at a lower efficiency than
the wtUba1-wtUbc1 pair. These results suggested that the
A7-xE2 pair is functional in transferring wtUB to the HECT
domains of E3 enzymes. However, the mutations in the H1 helix
of xE2 may interfere with the binding of xE2 to the native E3
enzymes. Therefore, further engineering work needs to be
done to create specific xE2-xE3 pairs.1272 Chemistry & Biology 19, 1265–1277, October 26, 2012 ª2012 ENew xE1-xE2 Pairs Can Be Constructed with Other
E2s by Swapping the H1 Helix from Phage-Selected
Ubc1 Mutant
Our phage selection results demonstrated that the H1 helices of
E2 enzymes played a dominant role in bridging the interactions
between E1 and E2. A sequence alignment of E2 enzymes
involved in UB transfer also reveals a highly conserved H1 helix
that is heavily populated with positively charged residues (Fig-
ure 4C). The sequence homology of the H1 helix reflects the
structural requirement imposed on various E2 enzymes to bind
to the same UFD domain of the E1 for UB transfer (Lee and
Schindelin, 2008). We thus thought that replacing the H1 helix
in a different E2 subtype with the mutated H1 helix of an Ubc1
clone might yield a ‘‘hybrid E2’’ unable to bind wtE1 but able to
interact with A7 for UB transfer. In this way, we could construct
new xE1-xE2 pairs with various E2 subtypes simply by sub-
stituting the native H1 helix with the mutated H1 helix of Ubc1.
To test this idea, we replaced the first 12 residues of UbcH7
(MAASRRLMKELE) constituting the H1 helix with the corre-
sponding sequences of Ubc1 mutants C2 (MSRADDIMDQIH)
and C9 (MSRADEIMEQIL) (Figure 4C; Table 1). We refer to the
H1-swapped forms of UbcH7 as C2-UbcH7 and C9-UbcH7,
respectively. We then tested the ability of C2-UbcH7 and
C9-UbcH7 to take up UB from wtE1 and A7. A western blot
of the UB transfer reaction showed that, while neither hybrid
can be loaded with UB by the wtE1 (Figure 5A), C9-UbcH7
can efficiently uptake UB from A7 (Figure 5B). In contrast, the
C2-UbcH7 cannot form UBE2 conjugates catalyzed by A7,
suggesting that a subtle difference in the H1 sequence may
strongly affect the efficiency of UB transfer from E1 to E2. Since
wtUbcH7 cannot be loaded with UB by A7 (Figure 5B), the
replacement of the native H1 helix in UbcH7 with the H1 helix
in C9 mutant restored the binding and reactivity of the hybrid
UbcH7 with A7. We further confirmed that the C9-UbcH7 hybrid
could transfer UB to the HECT domain of E6AP (Figure 5C). The
formation of an UBHECT conjugate is dependent on the
presence of both A7 and the C9-UbcH7 in the reaction mixture.
Overall, these results suggested that the native H1 helix of E2
enzyme could be swappedwith themutated H1 helix from phage
selection for the construction of xE1-xE2 pairs that are orthog-
onal to the native enzymes.
An xE1-xE2 Cascade that Is Orthogonal
to the Native E1 and E2 Enzymes for xUB Transfer
We next tested if the xUB-xE1(A) pair that we engineered could
relay with the A7-xE2 pairs to assemble an UB transfer cascade
from xE1 to xE2 that was orthogonal to the native E1 and E2
enzymes.We combined themutations in the adenylation domain
of A4, A5, and A6, demonstrated to function as xE1(A), with the
mutations in the UFD domain of A7 to generate Uba1 mutants
A8, A9, and A10 (Table 1). The xE1s with combined mutations
in the A and UFD domains should only recognize xUB and xE2
and transfer xUB to xE2. They should neither activate wtUB to
transfer it to xE2, nor should they activate xUB and transfer it
to native E2 enzymes. To test the reactivity of the xE1-xE2
cascade for xUB transfer, we used a combination of xE1 and
xE2 to synthesize xUBxE2 conjugates. We also cross-reacted
xUB with wtE1 and wtE2, or wtUB with xE1 and xE2, to test the
orthogonality of the xE1-xE2 cascade with the wtE1-wtE2lsevier Ltd All rights reserved
Figure 5. Reactivity of xE1 with Hybrid
UbcH7 and UbcH5a
(A) wtUB transfer to the hybrid UbcH7 from
wtUba1.
(B) wtUB transfer to the hybrid UbcH7 from
Uba1-A7.
(C) wtUB transfer to the HECT domain of E6AP
from A7 and hybrid C9-UbcH7.
(D) xUB (UB10) transfer by xE1 (Uba1-A9) with
combined A domain and UFD domain mutations
to the hybrid E2s in which the N-terminal H1
helixes of native UbcH5a and UbcH7 were re-
placed with the sequences of Ubc1 mutants from
phage selection.
See also Figure S7.
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could activate xUB and transfer xUB to xE2 for the formation
of xUBxE2 conjugates. In contrast, when xE1 or both xE1
and xE2 were replaced by the wtE1 or wtE2 enzymes, no xUB
transfer to thewtE1 or wtE2 enzymewas observed. Furthermore,
wtUB could not be transferred by the xE1-xE2 cascade for
the formation of wtUBxE2 conjugates (Figure 6B). These
results proved that the xE1-xE2 pair we engineered was indeed
an orthogonal pathway for the transfer of xUB to a specific xE2
enzyme.
We also found that hybrid E2s generated by replacing the
N-terminal H1 helix of the wtE2 with the phage-selected H1
sequence could pair with xE1 with combined mutations to
support the transfer of xUB.When A9was used as an xE1 to acti-
vate xUB, we observed that C9-UbcH7 can be loaded with xUB
catalyzed by xE1 (Figure 5D). Similarly, we generated C1-
UbcH5a (Figure 4C; Table 1) and found that C1-UbcH5a could
be loaded with xUB by A9 (Figure 5D). We also observed that
C9-UbcH5a and C2-UbcH7 were not able to interact properly
with A9 and be loaded with xUB further supporting the view
that the sequence of the H1 helix might significantly affect xUB
transfer. Overall, these results prove that we could engineer
E1 interfaces with UB and E2 to specifically transfer xUB to
an engineered xE2 enzyme and construct an xE1-xE2 cascade
that is orthogonal to native E1 and E2 enzymes.
DISCUSSION
Engineering Protein Posttranslational Modification
Enzymes with Orthogonal Reactivity for the Elucidation
of Cellular Signaling Pathways
Protein ubiquitination in the cell is complicated by the cross-
reactivities among E1, E2, and E3 enzymes (Figure S1A). These
enzymes assemble overlapping and intersecting networksChemistry & Biology 19, 1265–1277, October 26, 2012 ªfor UB transfer to the cellular target
proteins. The complexity of the E1-E2-
E3 cascades makes it a significant
challenge to identify the ubiquitination
substrates of a specific E3 enzyme and
elucidate the protein ubiquitination
pathways. Many enzymes responsible
for protein posttranslational modification
(PTM) share the same complexity asthe E1-E2-E3 cascade (Walsh, 2005). Typically, they exist in
the cell in many subtypes and cross-react to modify substrate
proteins. Since various subtypes of the same class of PTM
enzymes attach the same modification group on the cellular
proteins, it has been difficult to identify the direct substrates of
a specific PTM enzyme in the cell.
One strategy to elucidate the complex protein modification
pathways is to engineer the PTM enzymes so that they can
have orthogonal catalytic activities with the native enzymes.
One successful example is to engineer kinases to use an ATP
analog for protein phosphorylation. The ATP analog is not
recognized as a substrate by 500 or so native kinases (Manning
et al., 2002). When the ATP analog-engineered kinase pair is
applied to cellular proteins, only the targets of the engineered
kinase are phosphorylated by the radioactive ATP analog. The
identification of radiolabeled proteins in the cell leads to the
elucidation of the substrate proteins of the kinase. The engi-
neering of specific ATP analog- kinase pair removes the cross-
reactivity of ATP with the native kinases (Liu et al., 1998; Shah
et al., 1997). It creates a separate path for the transfer of phos-
phate to the modification targets of a specific kinase and greatly
facilitates the elucidation of the substrate proteins of individual
kinases (Bishop et al., 2000).
Adopting a similar strategy, we used protein engineering to
create xUB-xE1 and xE1-xE2 pairs that are orthogonal to their
native enzyme counterparts. Through the relay of the engi-
neered xE1 and xE2, an affinity-tagged xUB can be exclusively
transferred to a designated xE2. We have thus created a sepa-
rate path to synthesize xUBxE2 thioesters without cross-
reactivities with the native UB transfer pathways. Potentially,
xUB can be further transferred to the partner E3s of xE2 and
to the substrates of the E3 enzymes. So far, about 50 E2s
have been identified in the human genome. They are loaded
with UB by the two E1 enzymes that show overlapping yet2012 Elsevier Ltd All rights reserved 1273
Figure 6. Orthogonal Transfer of xUB from
xE1 to xE2
(A) Uba1 mutants A8, A9, and A10 can function as
xE1 to transfer xUB (UB10) to the C9 mutant of
Ubc1 (xE2).
(B) wtUB cannot be transferred by the xE1s to xE2.
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can also interact with multiple E3 enzymes and deliver UB to
their substrate proteins. Because of the complex cross-reactiv-
ities of E2s with E1 and E3 enzymes, the biological functions of
individual E2s are hard to define. We envision that we can use
the xE1-xE2 pair to synthesize a specific xUBxE2 conjugate
in the presence of the native E2s in the cell. By identifying
the cellular proteins modified with xUB, the UB transfer targets
of xE2 and the corresponding native E2 can be revealed.
This will help to elucidate the biological functions of individual
E2 enzymes. The creation of the xE1-xE2 pair in this study
also brings us one step closer to the construction of an OUT
system that transfers xUB through the xE1-xE2-xE3 cascade
to the substrate proteins of xE3 (Figure 1A). We are currently
engineering specific xE2-xE3 pairs with HECT and RING types
of E3s.
Catalysis-Based Phage Selection to Engineer Specific
xUB-xE1 and xE1-xE2 Pairs
In this study, we developed phage selection methods based on
E1-catalyzed UB transfer to engineer specific interactions
between xUB and xE1, and between xE1 and xE2. To select
for specific UB-E1 pairs, we displayed an UB library on the
phage with randomized C-terminal residues. UB clones that
were catalytically active with the E1 mutant xE1(A) would be
covalently bound to E1 by thioester linkages and be immobilized
on the streptavidin plate coatedwith the E1 enzyme (Figure S4A).
To select for specific E1-E2 pairs, we displayed an E2 library with
randomized H1 helix on phage. We then used the E1 mutant
xE1(UFD) to transfer biotin-UB to the E2 variants displayed on
phage surface. If the E2 variants are recognized by xE1(UFD)
to relay UB transfer, the E2 clone will form thioester conjugates
with biotin-UB and be selected by binding to the streptavidin
plate (Figure 4B). The catalysis-based phage selection methods
are more preferable than binding-based selection since the
binding affinity of the noncovalent UB-E1 and E1-E2 complex
are weak with Kds in the range of 0.3–5 mM (Burch and Haas,
1994; Eletr et al., 2005; Huang et al., 2008). Various UBL proteins
such as Nedd8 (Hori et al., 1999), SUMO (Johnson, 2004), and
ISG15 (Loeb and Haas, 1992) adopt similar cascade reactions
with their own sets of E1 and E2 enzymes for protein modifica-
tion. We expect that the phage selection methods we developed
to engineer UB transfer pathways can also be used to manipu-
late the reactivities of UBLs with the cognate E1 and E2
enzymes.1274 Chemistry & Biology 19, 1265–1277, October 26, 2012 ª2012 Elsevier Ltd All rights resEngineering Key Interactions
between UB and E1
Based on the results of phage selection,
we generated Arg42Glu and Arg72Glu
mutants of UB and identified mutationsin Uba1 that complement the mutations in UB for the assembly
of a specific xUB-xE1 pair. The importance of Arg42 and Arg72
of UB in E1 binding is well established in the literature. Previous
mutagenesis studies showed that both Arg72Leu and Arg42Leu
mutations lead to higher Kd for E1 binding when compared to wt
(Burch and Haas, 1994). In another study, alkylation of Arg42
and Arg72 of UB was found to attenuate the activity of UB to
stimulate ATP-PPi exchange with E1 by more than 85% (Duerk-
sen-Hughes et al., 1987). Arg72 of UB was also found to be
a gatekeeping residue to prevent UB from reacting with the E1
enzyme of the UBL protein Nedd8 (Souphron et al., 2008). UB
and Nedd8 share 58% sequence identity, and they have almost
the same C-terminal sequence except that Nedd8 has an Ala
residue replacing Arg72 of UB. Despite their high degree of
homology, UB and Nedd8 each have their own E1s to activate
their transfer to the target proteins (Schulman and Harper,
2009).When Arg72 of UBwasmutated to Ala or Leu, it was found
that the UB mutant can be activated by the E1 of Nedd8 (Bohn-
sack andHaas, 2003; Souphron et al., 2008;Walden et al., 2003).
This reveals that a key function of the Arg72 residue of UB is to
ensure the specific recognition of UB by its own E1. The impor-
tance of Arg42 and Arg72 for the biological activities of UB has
also been demonstrated in yeast complementation studies. It
was shown that, when Arg42 or Arg72 of UB was mutated to
Ala, the mutant UB was not able to complement the growth of
a yeast strain in which all endogenous UB genes were deleted
(Sloper-Mould et al., 2001).
Our studies verify the key roles of Arg42 and Arg72 in E1
recognition. We found that Arg42Glu and Arg72Glu mutations
in UB block the activation of the UB mutant (xUB) by E1. To
engineer an E1 mutant (xE1) that can bind and activate xUB,
we mutated residues Gln576, Ser589, and Asp591 in Uba1 to
Arg so that the newly introduced Arg residues in E1 can pair
with the Glu residues at positions 42 and 72 of UB to restore
UB-E1 interaction (Figures S2B and S2C). This resulted in
successful construction of a specific xUB-xE1 pair for xUB
activation.
Using the H1 Helix of E2 to Engineer
an E1-E2 Interaction
The modeled structure of Uba1-Ubc1 complex suggests that
electrostatic interactions between the UFD domain of Uba1
and the H1 helix of Ubc1 play important roles in E1-E2 interac-
tion (Lee and Schindelin, 2008) (Figures S2A and S2D). We
mutated Glu1004, Asp1014, and Glu1016 of Uba1 to positivelyerved
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mutations, the A7 mutant of Uba1 that we refer to as xE1(UFD)
can no longer bind to native E2s. We carried out phage selec-
tion on an Ubc1 library with randomized residues in the H1 helix
to identify complementary mutations that restore the E1-E2
interaction. Phage selection enriched negatively charged resi-
dues such as Asp and Glu at positions 5, 6, and 9 of Ubc1,
matching well with the counter charges introduced by the Lys
mutations in A7 (Figure 4C). It is interesting that a Glu10Gln
mutation in the H1 helix seems to dominate the Ubc1 library
after phage selection suggesting the importance of the muta-
tion to A7-xE2 interaction. It is not evident from the modeled
structure of Uba1-Ubc1 complex (Lee and Schindelin, 2008)
why a neutral Gln residue replacing the negatively charged
Glu in the H1 helix could lead to a better binding between
mutant Ubc1 (xE2) and A7 (Figure S2D). The unexpected selec-
tion of the Glu10Gln mutation in Ubc1 library demonstrates the
effectiveness of phage display in optimizing protein-protein
interactions between E1 and E2.
Our study suggests that the H1 helix of E2 can be engineered
to create specific xE1-xE2 pairs. Previous mutagenesis studies
showed that the H1 helix of E2s plays an important role to bridge
the E1-E2 interaction. Mutations in the H1 helix of E2s such
as Ubc1, Ubc4, and Cdc34 have been found to impair the
formation of UBE2 conjugates catalyzed by E1 (Lee and
Schindelin, 2008; Pitluk et al., 1995; Sullivan and Vierstra,
1991). Here we used phage display to redesign the sequence
of the H1 helix in xE2 to remove its binding with the wtE1 and
to generate specific interactions between xE2 and xE1. We
also showed that the H1 helix from phage selection is portable
to other E2s, such as UbcH5a and UbcH7, for the construction
of xE1-xE2 pairs. These pairs create a separate path to transfer
xUB to a specific E2 enzyme.
SIGNIFICANCE
The human genome encodes 2 E1s, 50 E2s, and more than
1,000 E3s. Together, they assemble the complex network
of UB transfer in the cell. Because of the complex cross-
reactivities among E1, E2, and E3 enzymes, it has been
a challenge to individually assign the biological function
of E2 and E3 enzymes. We plan to identify the substrate
proteins of a specific E3 enzyme by constructing an
orthogonal UB transfer (OUT) cascade that is composed
of engineered E1, E2, and E3 enzymes (xE1, xE2, and
xE3). Through this cascade, an affinity-tagged UB mutant
(xUB) can be activated and transferred to the substrate
proteins of a specific E3 in order to elucidate the cellular
targets of individual E3 enzymes. To construct the OUT
cascade, we used a combination of catalysis-based phage
selection and site-directed mutagenesis to engineer xUB-
xE1 and xE1-xE2 pairs that are free of cross-reactivity
with their native enzyme counterparts. We further com-
bined the engineered xUB-xE1 and xE1-xE2 pairs to imple-
ment an orthogonal pathway to activate xUB and transfer
it to a specific E2 for protein ubiquitination. We have thus
accomplished the first two steps of a three-step protein
engineering sequence for the construction of an OUT
cascade.Chemistry & Biology 19, 1265–1EXPERIMENTAL PROCEDURES
Phage Selection of the UB Library
Phage library selection followed the same procedure as the model
selection. To initiate the reaction between phage-displayed UB and the
A1 mutant of Uba1, 100 ml of phage displaying the UB library was added
to each well of the streptavidin plate coated with the PCP fusion of
Uba1-A1. For the first round of selection, 1 3 1011 UB library phage in
100 ml reaction buffer was added to each well that was coated with the
A1 mutant at a level of 125 pmol per well. The reaction was allowed to
proceed for 1 hr at room temperature. The supernatant was discarded,
and the plate was washed 30 times with Tris-buffered saline (TBS) con-
taining 0.1% Tween 20 and 30 times with TBS, each time with 200 ml of
solution per well. After washing, phage bound to the streptavidin surface
were eluted by adding 100 ml 10 mM DTT in TBS to each well with
10 min incubation. The eluted phage were combined, added to 10 ml of
log-phase Escherichia coli XL1-Blue cells, and shaken at 37C for 1 hr to
infect the cells. The cells were then plated on Luria broth (LB) agar plates
supplemented with 2% (w/v) glucose and 100 mg/ml ampicillin. After over-
night incubation at 37C, colonies on the plates were scratched and
the phagemid DNA was extracted with a QIAprep plasmid miniprep kit
(QIAGEN). The phagemid DNA was then used for the next round of phage
production and selection. During phage selection, control reactions were
also set up in which ATP was eliminated from the reaction or plain strepta-
vidin coated well with no PCP-A1 binding was used for selection. Phage
particles eluted from the selection or the control reactions were titered.
After the first round of selection, the number of the input phage particles,
the amount of PCP-A1 on the plate, and the reaction time were decreased
in the subsequent selection rounds to make the selection more stringent.
Eventually, 1010 phage particles were incubated in each well with 5 pmol
of PCP-A1 for 10 min at room temperature during the sixth round of selec-
tion. After six rounds of selection, phage clones were sequenced with the
Jun13 primer.
Phage Selection of the Ubc1 Library
Library selection followed the same procedure as the model selection. In the
first round of selection, 500 ml reactions were set up with 1 mM A7, 5 mM
biotin-UB, 2.5 mM ATP, 50 mM MgCl2, and 7.5 3 10
11 Ubc1 library phage
in TBS buffer (pH 7.5). The reaction was allowed to proceed for 1 hr at
room temperature before 3% BSA in TBS buffer (pH 7.5) was added to a final
BSA concentration of 1%. The phage solution was then distributed into the
wells of a streptavidin-coated plate. The streptavidin plate was incubated at
room temperature for 1 hr. The supernatant was discarded, and the plate
was washed 30 times with 0.05% (v/v) Tween 20, 0.05% (v/v) Triton X-100
in TBS, and 30 times with TBS, each time with 200 ml of solution per well.
After washing, phage bound to the streptavidin surface were eluted by add-
ing 100 ml 10 mM DTT in TBS to each well and incubating for 10 min. The
eluted phage were combined, added to 10 ml of log phase E. coli XL1-
Blue cells, and shaken at 37C for 1 hr to infect the cells. The cells were
then plated on LB agar plates supplemented with 2% (w/v) glucose and
100 mg/ml ampicillin. After overnight incubation at 37C, colonies on the
plates were scratched, and the phagemid DNA was extracted with a QIAprep
Plasmid Miniprep kit (QIAGEN). The phagemid DNA was then used for the
next round of phage production and selection. Also, phage particles eluted
from the selection or the control reactions were titered. After the first round
of selection, the number of the input phage particles, the concentration of A7
and biotin-UB, and the reaction time were decreased in the subsequent
selection rounds to make the selection more stringent. Eventually, 1010
phage particles were incubated with 0.1 mM biotin-UB, 0.05 mM A7 for
5 min at room temperature for the eighth round of selection. After the
seventh and eighth rounds of selection, phage clones were sequenced
with the Jun13 primer.
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